AEGIS ANALYTICAL CORP has a total of 21 patent applications. Its first patent ever was published in 1999. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets computer technology, machines and it methods for management are LU LI-CHIH, JAIN MANISHA and MORINVILLE PAUL V.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Australia | 3 | |
#4 | Japan | 3 | |
#5 | United States | 3 | |
#6 | Canada | 2 | |
#7 | China | 1 | |
#8 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Computer technology | |
#2 | Machines | |
#3 | IT methods for management | |
#4 | Environmental technology | |
#5 | Control | |
#6 | Audio-visual technology | |
#7 | Medical technology | |
#8 | Engines, pumps and turbines |
# | Name | Total Patents |
---|---|---|
#1 | Neway Justin | 10 |
#2 | Neway Justin O | 6 |
#3 | Jahn Gretchen L | 5 |
#4 | Durfee Steven L | 5 |
#5 | Ruth Joseph | 4 |
#6 | Galemmo Nicholas | 4 |
#7 | Dorr Susan | 4 |
#8 | Junak Jeffrey | 4 |
#9 | Liboudan Olivier | 4 |
#10 | Junak Jeffrey A | 3 |
Publication | Filing date | Title |
---|---|---|
KR20140093611A | A system for designating, displaying and selecting types of process parameters and product outcome parameters | |
WO2012151499A2 | A system for designating, displaying and selecting types of process parameters and product outcome parameters | |
EP2704682A2 | A system for designating, displaying and selecting types of process parameters and product outcome parameters | |
AU2002323532A1 | An advanced method for profile analysis of continuous data | |
EP1585035A1 | System, method and computer program product for mapping data of multi-database origins | |
US6725230B2 | System, method and computer program for assembling process data of multi-database origins using a hierarchical display | |
US6243615B1 | System for analyzing and improving pharmaceutical and other capital-intensive manufacturing processes |